India, April 23 -- Shares of Ensysce Biosciences, Inc. (ENSC) gained over 91% on Wednesday morning after the company said it received U.S. patent for treatment of opioid use disorder.
ENSC is currently trading at $3.5820, up $1.7120 or 91.4042%, on a huge volume of 70 million shares, compared to average volume of 75 thousand, on the Nasdaq. The stock opened its trading at $4.2400 after closing Tuesday at $1.8700. The stock has traded between $1.6200 and $14.6700 in the past 52-week period.
The company announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for the issuance of a patent entitled: Enzyme-Cleavable Methadone Prodrugs and Methods of Use Thereof including both composition of matter and method ...